Mealey's (April 10, 2023, 1:39 PM EDT) -- Two federal courts on April 7 issued conflicting orders regarding the availability of the abortion drug mifepristone, with a Texas judge staying the Food and Drug Administration’s 23-year-old approval of the drug and a Washington federal judge enjoining the FDA from altering the drug’s regulatory approval status....